News for Your Practice

New overactive bladder treatment approved by FDA

Author:

Deborah Reale

Myrbetriq (mirabegron) from Astellas is the first beta-3 adrenergic agonist accepted for OAB

• Read More

News for Your Practice

New data: HIV-infected women do not have an elevated risk of cervical cancer

Author:

Janelle Yates

A recent study found similar rates of cervical precancer and cancer among HIV-infected women and HIV-negative women who had normal cervical...

• Read More

Clinical Review

Malpositioned IUDs: When you should intervene (and when you should not)

Author:

Kari P. Braaten, MD, MPH

A malpositioned intrauterine device may not be a complication requiring action. Knowing how to manage the situation optimally for your patients...

• Read More

Clinical Review

UPDATE ON CONTRACEPTION

Author:

Tami Rowen, MD, MS

Highlights (and lowlights) from the past year in contraception: the US unintended pregnancy rate and controversies in providing contraception.

• Read More

Commentary

Repeat the US before going to MRI … and more

• Read More

From the Editor

Let’s increase our use of IUDs and improve contraceptive effectiveness in this country

Author:

Robert L. Barbieri, MD

The unintended pregnancy rate is too high in the United States, and the use of long-acting reversible contraceptives is too low. Expanding the...

• Read More

Expert Commentary

What is the optimal interval for osteoporosis screening in postmenopausal women before fracture occurrence and osteoporosis treatment initiation?

Author:

Steven R. Goldstein, MD

It varies, depending on baseline T score.

• Read More

Product Review

PRODUCT UPDATE

• Read More

Audio

Safe abdominal entry techniques

Author:

Michael Baggish, MD

Hear concrete guidance on abdominal entry tools and techniques for safe entry during gynecologic laparoscopy, as well as Dr. Baggish's description...

• Read More